Skip to main content

ADVERTISEMENT

James P. Zidar, MD

Review
08/01/2008
Over the past decade, impressive reductions in mortality, reinfarction and length of hospital stay have been reported in large-scale studies of patients with acute coronary syndrome (ACS). Despite these advances, substantial challenges remain...
Over the past decade, impressive reductions in mortality, reinfarction and length of hospital stay have been reported in large-scale studies of patients with acute coronary syndrome (ACS). Despite these advances, substantial challenges remain...
Over the past decade, impressive...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Hall Whitworth: We have performed about 350 cases at our center and it has evolved somewhat over the last couple of years. Initially, we used the CheckMate system because of its greater length. The pullback and stepping techniques have...
Hall Whitworth: We have performed about 350 cases at our center and it has evolved somewhat over the last couple of years. Initially, we used the CheckMate system because of its greater length. The pullback and stepping techniques have...
Hall Whitworth: We have...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
Part II of III - Continued TABLE 3 KEY (continued) 2) Unfractionated heparin(UFH) can be used as an alternative to enoxaparin. If UFH is used in the setting of PCI, activated clotting time (ACT) should be followed to achieve an appropriate...
Part II of III - Continued TABLE 3 KEY (continued) 2) Unfractionated heparin(UFH) can be used as an alternative to enoxaparin. If UFH is used in the setting of PCI, activated clotting time (ACT) should be followed to achieve an appropriate...
Part II of III -...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Hall Whitworth: There is another subset of patients who will be asking for these new drug-coated stents: those with long, diffuse distal disease. We may decide to treat such patients medically, but they too will be clamoring for the new...
Hall Whitworth: There is another subset of patients who will be asking for these new drug-coated stents: those with long, diffuse distal disease. We may decide to treat such patients medically, but they too will be clamoring for the new...
Hall Whitworth: There is another...
08/01/2008
Journal of Invasive Cardiology
Review
08/01/2008
A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...
A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...
A total of 5,225 patients were...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
The High Mortality Among Patients in Cardiogenic Shock “LV or RV Infarcts:” What Have We Learned and Have We Made a Difference? In this symposium, we will revisit the treatment of cardiogenic shock complicating acute myocardial infarction...
The High Mortality Among Patients in Cardiogenic Shock “LV or RV Infarcts:” What Have We Learned and Have We Made a Difference? In this symposium, we will revisit the treatment of cardiogenic shock complicating acute myocardial infarction...
The High Mortality Among...
08/01/2008
Journal of Invasive Cardiology
Education
05/28/2019
Journal of Invasive Cardiology
08/01/2008
Case Report. The patient was a 76-year-old male with the cardiovascular risk factors of hypertension and hyperlipidemia. His cardiovascular history began in April 2000, with a myocardial infraction (MI) of the anteroseptal wall; although, he...
Case Report. The patient was a 76-year-old male with the cardiovascular risk factors of hypertension and hyperlipidemia. His cardiovascular history began in April 2000, with a myocardial infraction (MI) of the anteroseptal wall; although, he...
Case Report. The patient was a...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Part ii Continuation of discussion Supporting Patients in Shock Jeff Werner: I have a question for Dr. Shawl. I believe you said that you think patients should be completely revascularized during acute infarction using angioplasty and...
Part ii Continuation of discussion Supporting Patients in Shock Jeff Werner: I have a question for Dr. Shawl. I believe you said that you think patients should be completely revascularized during acute infarction using angioplasty and...
Part ii Continuation of...
08/01/2008
Journal of Invasive Cardiology